NIH launches $5–50M research awards to bypass bureaucracy, fund breakthrough science
H.R. 6572 — Launching X–Labs for Breakthrough Science Act · Filed by Josh Harder (D-CA) · 1 cosponsor · Introduced Dec 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a new NIH program called the X-Labs Initiative that awards $5–50 million per year (for 7 years, renewable once) to innovative research institutions—including nonprofits, universities, and focused research organizations—to conduct breakthrough biomedical research and acquire research facilities. Institutions receiving the largest awards (XL01–XL03) must forgo other federal research grants during the award period; smaller planning grants (XL04) are non-renewable. The program aims to reduce administrative burden and fund high-risk, high-reward research that traditional NIH grants might miss.
Why we flagged it
The bill's core mechanism is a straightforward authorization of new NIH institutional awards for breakthrough biomedical research. It creates a new funding category and eligibility framework; it does not deregulate, privatize, or create hidden carve-outs.
What the text implies
- The dual-funding prohibition (section 404P(7)) may inadvertently exclude institutions that rely on multiple federal sources (e.g., NSF, DOE, DARPA co-funding), potentially narrowing the eligible pool to well-capitalized or single-mission organizations.
- XL03 funding (regrant mechanism) creates a two-tier distribution system where intermediary nonprofits decide which researchers receive support, introducing discretion and potential bias in identifying 'unlikely to receive support through traditional NIH grants' teams.
The full analysis lists 4 implications of this text.
Who stands to gain
nonprofit research organizations; institutions of higher education; focused research organizations